Abstract
Intraocular lens development is driven by higher patient expectations for ideal visual outcomes. The recently US Food and Drug Administration-approved Softec HD™ lens is an aspheric, hydrophilic acrylic intraocular lens (IOL). The hydrophilic design of the lens is optimized to address dysphotopsia while maintaining biocompatibility, optical clarity, resistance to damage, and resistance to biocontamination. Aspheric lenses decrease postoperative spherical aberration. The addition of the Softec lens provides clinicians with another option for IOL placement; however, randomized comparative studies of this lens to others already on the market remain to be completed. © 2011 Espandar et al, publisher and licensee Dove Medical Press Ltd.
Author supplied keywords
Cite
CITATION STYLE
Espandar, L., Sikder, S., & Moshirfar, M. (2011). Softec HD hydrophilic acrylic intraocular lens: Biocompatibility and precision. Clinical Ophthalmology. https://doi.org/10.2147/OPTH.S12290
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.